Payment overview · 2025
General Payments
$113.60
6 reported records · 4 companies
Healthcare provider profile · identity verified
Sandra K Quick, FNP
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family · COLUMBIA, SC · NPI 1649262288
Verified facts
What the public records show
CMS Open Payments records show Sandra K Quick, FNP received $113.60 in general payments during 2025 across 6 reported records.
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) accounted for 53.3% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 4 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | Unresolved — no canonical attribution shown | $60.52 | 53.3% | 3 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $22.08 | 19.4% | 1 | 2025 |
| Lundbeck LLC | Unresolved — no canonical attribution shown | $16.98 | 14.9% | 1 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $14.02 | 12.3% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $113.60 | 6 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| CAPLYTA Normalized: caplyta |
Drug | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $60.52 | 3 | 2025 |
Source payment records
|
|||||
| OTEZLA Normalized: otezla |
Drug | Amgen Inc. | $22.08 | 1 | 2025 |
Source payment records
|
|||||
| REXULTI Normalized: rexulti |
Drug | Lundbeck LLC | $16.98 | 1 | 2025 |
Source payment records
|
|||||
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $14.02 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Alprazolam | Alprazolam | 504 | 65 |
| Gabapentin | Gabapentin | 427 | 91 |
| Atorvastatin Calcium | Atorvastatin Calcium | 415 | 124 |
| Omeprazole | Omeprazole | 404 | 103 |
| Amlodipine Besylate | Amlodipine Besylate | 330 | 96 |
| Furosemide | Furosemide | 258 | 73 |
| Metoprolol Succinate | Metoprolol Succinate | 253 | 64 |
| Hydrochlorothiazide | Hydrochlorothiazide | 247 | 68 |
| Zolpidem Tartrate | Zolpidem Tartrate | 217 | 30 |
| Losartan Potassium | Losartan Potassium | 210 | 57 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 205 | 52 |
| Levothyroxine Sodium | Levothyroxine Sodium | 199 | 51 |
| Pravastatin Sodium | Pravastatin Sodium | 191 | 58 |
| Potassium Chloride | Potassium Chloride | 167 | 49 |
| Lisinopril | Lisinopril | 152 | 43 |
| Eliquis | Apixaban | 144 | 27 |
| Linzess | Linaclotide | 141 | 36 |
| Pantoprazole Sodium | Pantoprazole Sodium | 141 | 37 |
| Tramadol Hcl | Tramadol Hcl | 139 | 34 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 137 | 46 |
| Ropinirole Hcl | Ropinirole Hcl | 133 | 25 |
| Tamsulosin Hcl | Tamsulosin Hcl | 132 | 37 |
| Metformin Hcl | Metformin Hcl | 122 | 41 |
| Metoprolol Tartrate | Metoprolol Tartrate | 121 | 35 |
| Montelukast Sodium | Montelukast Sodium | 120 | 40 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 119 | 24 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 118 | 27 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 111 | 46 |
| Meloxicam | Meloxicam | 111 | 33 |
| Carvedilol | Carvedilol | 106 | 33 |
| Hydralazine Hcl | Hydralazine Hcl | 104 | 27 |
| Lorazepam | Lorazepam | 104 | 21 |
| Clopidogrel | Clopidogrel Bisulfate | 102 | 24 |
| Donepezil Hcl | Donepezil Hcl | 102 | 21 |
| Temazepam | Temazepam | 99 | 20 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 98 | 24 |
| Trazodone Hcl | Trazodone Hcl | 98 | 24 |
| Farxiga | Dapagliflozin Propanediol | 97 | 25 |
| Pregabalin | Pregabalin | 97 | 23 |
| Simvastatin | Simvastatin | 96 | 30 |
| Promethazine Hcl | Promethazine Hcl | 91 | 27 |
| Clonazepam | Clonazepam | 90 | 14 |
| Allopurinol | Allopurinol | 89 | 27 |
| Fluticasone Propionate | Fluticasone Propionate | 88 | 32 |
| Glipizide Er | Glipizide | 88 | 25 |
| Ozempic | Semaglutide | 86 | 27 |
| Prednisone | Prednisone | 86 | 36 |
| Ibuprofen | Ibuprofen | 83 | 34 |
| Azithromycin | Azithromycin | 81 | 58 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 80 | 12 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 80 | 24 |
| Amoxicillin | Amoxicillin | 76 | 48 |
| Sertraline Hcl | Sertraline Hcl | 76 | 18 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 76 | 48 |
| Mounjaro | Tirzepatide | 73 | 14 |
| Spironolactone | Spironolactone | 73 | 18 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 72 | 24 |
| Glipizide | Glipizide | 69 | 22 |
| Methylprednisolone | Methylprednisolone | 69 | 59 |
| Diazepam | Diazepam | 68 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 68 | 19 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 68 | 18 |
| Duloxetine Hcl | Duloxetine Hcl | 67 | 19 |
| Fluoxetine Hcl | Fluoxetine Hcl | 67 | 13 |
| Nitroglycerin | Nitroglycerin | 65 | 21 |
| Jardiance | Empagliflozin | 64 | 18 |
| Ondansetron Hcl | Ondansetron Hcl | 62 | 17 |
| Fluconazole | Fluconazole | 60 | 23 |
| Amitriptyline Hcl | Amitriptyline Hcl | 58 | 13 |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 56 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 54 | 17 |
| Mupirocin | Mupirocin | 53 | 29 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 52 | 11 |
| Ezetimibe | Ezetimibe | 51 | 16 |
| Baclofen | Baclofen | 50 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 50 | 14 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 50 | 13 |
| Celecoxib | Celecoxib | 49 | 13 |
| Famotidine | Famotidine | 47 | 13 |
| Citalopram Hbr | Citalopram Hydrobromide | 46 | 13 |
| Sucralfate | Sucralfate | 46 | 14 |
| Propranolol Hcl | Propranolol Hcl | 45 | 11 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 44 | 15 |
| Memantine Hcl | Memantine Hcl | 44 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 44 | 17 |
| Meclizine Hcl | Meclizine Hcl | 42 | 17 |
| Ondansetron Odt | Ondansetron | 42 | 20 |
| Quetiapine Fumarate | Quetiapine Fumarate | 39 | 16 |
| Benazepril Hcl | Benazepril Hcl | 38 | 14 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 38 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 36 | suppressed |
| Trulicity | Dulaglutide | 36 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 36 | suppressed |
| Valsartan | Valsartan | 35 | suppressed |
| Nifedipine Er | Nifedipine | 33 | 13 |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 31 | 12 |
| Oxycodone Hcl | Oxycodone Hcl | 31 | 13 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 30 | 21 |
| Atenolol | Atenolol | 30 | suppressed |
| Levetiracetam | Levetiracetam | 30 | suppressed |
| Clorazepate Dipotassium | Clorazepate Dipotassium | 29 | suppressed |
| Methimazole | Methimazole | 29 | suppressed |
| Xarelto | Rivaroxaban | 29 | suppressed |
| Olanzapine | Olanzapine | 28 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 27 | suppressed |
| Digoxin | Digoxin | 27 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 27 | 14 |
| Alendronate Sodium | Alendronate Sodium | 26 | suppressed |
| Bupropion Xl | Bupropion Hcl | 26 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 26 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 26 | 17 |
| Ibu | Ibuprofen | 25 | suppressed |
| Klor-Con M20 | Potassium Chloride | 24 | suppressed |
| Carisoprodol | Carisoprodol | 23 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 23 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 23 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 22 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 22 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 22 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 22 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 22 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 21 | suppressed |
| Ramipril | Ramipril | 21 | suppressed |
| Topiramate | Topiramate | 21 | suppressed |
| Alcohol Pads | Alcohol Antiseptic Pads | 20 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 20 | suppressed |
| Finasteride | Finasteride | 20 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 19 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 18 | 11 |
| Doxazosin Mesylate | Doxazosin Mesylate | 18 | suppressed |
| Vraylar | Cariprazine Hcl | 18 | suppressed |
| Armour Thyroid | Thyroid,pork | 17 | suppressed |
| Buprenorphine | Buprenorphine | 17 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 17 | suppressed |
| Hydrocortisone | Hydrocortisone | 17 | suppressed |
| Mirtazapine | Mirtazapine | 17 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 17 | suppressed |
| Entresto | Sacubitril/Valsartan | 16 | suppressed |
| Loperamide | Loperamide Hcl | 16 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 16 | suppressed |
| Rybelsus | Semaglutide | 16 | suppressed |
| Torsemide | Torsemide | 16 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 16 | suppressed |
| Benazepril-Hydrochlorothiazide | Benazepril/Hydrochlorothiazide | 15 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 15 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 15 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 15 | suppressed |
| Methocarbamol | Methocarbamol | 15 | suppressed |
| Nystatin | Nystatin | 15 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 15 | suppressed |
| Tiadylt Er | Diltiazem Hcl | 15 | suppressed |
| Ulticare Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 14 | 11 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 14 | suppressed |
| Colchicine | Colchicine | 14 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 14 | suppressed |
| Glyburide | Glyburide | 14 | suppressed |
| Irbesartan | Irbesartan | 14 | suppressed |
| Levofloxacin | Levofloxacin | 14 | suppressed |
| Pentasa | Mesalamine | 14 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 14 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 13 | suppressed |
| Chlorthalidone | Chlorthalidone | 13 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 13 | suppressed |
| Dutasteride | Dutasteride | 13 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 13 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 13 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 13 | suppressed |
| Lamotrigine | Lamotrigine | 13 | suppressed |
| Lovastatin | Lovastatin | 13 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 13 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 13 | suppressed |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 12 | suppressed |
| Febuxostat | Febuxostat | 12 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Lidocaine | Lidocaine | 12 | suppressed |
| M-Natal Plus | Pnv,calcium 72/Iron/Folic Acid | 12 | suppressed |
| Naproxen | Naproxen | 12 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 12 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 11 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 11 | suppressed |
| Estradiol | Estradiol | 11 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 11 | suppressed |
| Restasis | Cyclosporine | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $113.60 · 6 records | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA, Cologuard Collection Kit, OTEZLA, REXULTI | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error